M Michele Martins, MD in Waverly, IA - Medicare

M Michele Martins, MD is a medicare enrolled "Obstetrics & Gynecology" physician in Waverly, Iowa. Her current practice location is 312 9th St Sw, Waverly, Iowa. You can reach out to her office (for appointments etc.) via phone at (319) 483-4074.

M Michele Martins is licensed to practice in Iowa (license number 38951) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1427270792.

Contact Information

	M Michele Martins, MD
	312 9th St Sw, Waverly, IA 50677-2929
	(319) 483-4074
	(319) 352-8034

Physician's Profile

Full Name	M Michele Martins
Gender	Female
Speciality
Experience	Years
Location	312 9th St Sw, Waverly, Iowa
Accepts Medicare Assignments	Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

M Michele Martins attended and graduated from in

NPI Data:

NPI Number: 1427270792
Provider Enumeration Date: 05/03/2007
Last Update Date: 08/16/2010

Medicare PECOS Information:

PECOS PAC ID:
Enrollment ID:

Medical Identifiers

Medical identifiers for M Michele Martins such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1427270792	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207V00000X	Obstetrics & Gynecology	MT188975 (Pennsylvania)	Secondary
207V00000X	Obstetrics & Gynecology	38951 (Iowa)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. M Michele Martins is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
M Michele Martins, MD 312 9th St Sw, Waverly, IA 50677-2929 Ph: (319) 483-4074	M Michele Martins, MD 312 9th St Sw, Waverly, IA 50677-2929 Ph: (319) 483-4074

News Archive

FMBFarma granted exclusive rights to market Ampio's Zertane for PE in Brazil

Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, and FBM Industria Farmaceutica Ltda, a member of the HOSPFAR Group that manufactures, imports and distributes pharmaceuticals in Brazil, today announced a license and distribution agreement providing FMBFarma exclusive rights to market Zertane in Brazil for the treatment of premature ejaculation.

ACS NSQIP Pediatric helps hospitals prevent complications

A first of its kind surgical quality improvement program for children has the potential to identify outcomes of children's surgical care that can be targeted for quality improvement efforts to prevent complications and save lives. The results of a study of the American College of Surgeons National Surgical Quality Improvement Program-Pediatric (ACS NSQIP Peds) phase 1 pilot were published in the January issue of the Journal of the American College of Surgeons.

Study addresses the role of macrophage activation syndrome in COVID-19

Scientists review macrophage activation syndrome — a feature of the cytokine storm that kills patients with severe cases of COVID-19, as well as possible treatments.

Atypical protein kinase C stabilizes SRC-3 levels in breast cancer cells

A new study provides valuable insight into a previously undescribed mechanism that regulates a prominent cancer-associated protein.

New perspectives in type 2 diabetes, cardiovascular risk, and treatment goals

An article published in the May 2010 issue of Postgraduate Medicine highlights the seriousness of cardiovascular disease (CVD) in patients with type 2 diabetes. Cardiovascular disease is the cause of death in > 65% of patients with diabetes, and when complicated by the presence of obesity, the lifetime risk of developing CVD increases to 90%. The inherent problem is that many of the antihyperglycemic medications used to combat high glycated hemoglobin are associated with weight gain and/or hypoglycemia, which negatively affect CVD.

M Michele Martins, MD - Medicare in Waverly, IA